BRPI0719351A2 - Preparação adesiva estabilizada contendo donezepil - Google Patents

Preparação adesiva estabilizada contendo donezepil

Info

Publication number
BRPI0719351A2
BRPI0719351A2 BRPI0719351-3A2A BRPI0719351A BRPI0719351A2 BR PI0719351 A2 BRPI0719351 A2 BR PI0719351A2 BR PI0719351 A BRPI0719351 A BR PI0719351A BR PI0719351 A2 BRPI0719351 A2 BR PI0719351A2
Authority
BR
Brazil
Prior art keywords
donezepil
preparation containing
adhesive preparation
stabilized adhesive
stabilized
Prior art date
Application number
BRPI0719351-3A2A
Other languages
English (en)
Inventor
Akinori Hanatani
Satoko Washiro
Junichi Sekiya
Sachiko Terashi
Sumiyo Nishi
Hitoshi Akemi
Original Assignee
Nitto Denko Corp
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Eisai R&D Man Co Ltd filed Critical Nitto Denko Corp
Publication of BRPI0719351A2 publication Critical patent/BRPI0719351A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
BRPI0719351-3A2A 2006-12-01 2007-11-30 Preparação adesiva estabilizada contendo donezepil BRPI0719351A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86196506P 2006-12-01 2006-12-01
JP2006325104 2006-12-01
JP2007152016 2007-06-07
PCT/JP2007/073249 WO2008066180A1 (en) 2006-12-01 2007-11-30 Skin adhesive preparation comprising stabilized donepezil

Publications (1)

Publication Number Publication Date
BRPI0719351A2 true BRPI0719351A2 (pt) 2014-01-07

Family

ID=39467966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719351-3A2A BRPI0719351A2 (pt) 2006-12-01 2007-11-30 Preparação adesiva estabilizada contendo donezepil

Country Status (7)

Country Link
EP (2) EP2638906A1 (pt)
JP (2) JP5110711B2 (pt)
KR (1) KR20090086565A (pt)
BR (1) BRPI0719351A2 (pt)
CA (1) CA2671081C (pt)
TW (1) TW200838569A (pt)
WO (1) WO2008066180A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
EP3369421B1 (en) 2015-10-26 2020-06-03 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch
SG11201805570WA (en) 2015-12-30 2018-07-30 Corium Int Inc Systems and methods for long term transdermal administration
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
AU2017301928B2 (en) 2016-07-27 2023-04-06 Corium, LLC. Donepezil transdermal delivery system
US10945968B2 (en) 2016-07-27 2021-03-16 Corium, Inc. Memantine transdermal delivery systems
CA3031944A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
ES3001152T3 (es) 2016-12-20 2025-03-04 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
US10898448B2 (en) 2017-04-25 2021-01-26 Hisamitsu Pharmaceutical Co., Inc. Patch
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
EP3810099A1 (en) 2018-06-20 2021-04-28 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
KR102115102B1 (ko) * 2018-12-21 2020-05-26 동아에스티 주식회사 안정화된 도네페질 함유 경피 흡수제제
KR102218593B1 (ko) * 2020-05-13 2021-02-22 동아에스티 주식회사 안정성이 향상된 도네페질 함유 경피 흡수제제
JP7640598B2 (ja) * 2022-02-24 2025-03-05 久光製薬株式会社 ビソプロロール含有貼付剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3987655B2 (ja) 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
JP4073121B2 (ja) * 1998-08-28 2008-04-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の苦味等を軽減した組成物
ES2211056T3 (es) * 1999-03-31 2004-07-01 Eisai Co., Ltd. Composiciones estabilizadas que contienen farmacos nootropicos.
EP1437130A4 (en) * 2001-10-17 2009-08-26 Hisamitsu Pharmaceutical Co PERCUTANEOUS ABSORPTION PREPARATIONS
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
JP4950510B2 (ja) * 2006-02-16 2012-06-13 久光製薬株式会社 経皮吸収製剤

Also Published As

Publication number Publication date
JP5547784B2 (ja) 2014-07-16
TW200838569A (en) 2008-10-01
WO2008066180A1 (en) 2008-06-05
JP5110711B2 (ja) 2012-12-26
EP2098233A4 (en) 2012-03-21
KR20090086565A (ko) 2009-08-13
JPWO2008066180A1 (ja) 2010-03-11
JP2012255043A (ja) 2012-12-27
CA2671081C (en) 2014-06-03
CA2671081A1 (en) 2008-06-05
EP2098233A1 (en) 2009-09-09
EP2638906A1 (en) 2013-09-18

Similar Documents

Publication Publication Date Title
NO2021010I1 (no) telostritat ethyl
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
ATE524477T1 (de) Aziridinylepothilonverbindungen
DK2041139T3 (da) Farmaceutiske forbindelser
BRPI0821831A2 (pt) Compostos inseticidas
DK3354267T3 (da) Stabiliseret sulforaphan
DE502007004205D1 (de) Tt
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
FI20060389L (fi) Sensori
EP2047845A4 (en) GLUE PREPARATION
DK2084443T3 (da) Gennemføring
BRPI0815181A2 (pt) Compostos
DK2016067T3 (da) Insecticidforbindelser
EP2042580A4 (en) CONDUCTIVE ADHESIVE
EP2077583A4 (en) LIGHT DETECTION ARRANGEMENT
BRPI0820430A2 (pt) Composto
EP2077582A4 (en) LIGHT DETECTION ARRANGEMENT
EP2085088A4 (en) ADHESIVE PREPARATION
IS8607A (is) Stöðugar atorvastatin samsetningar
ES1063260Y (es) Envase auto-calentable
FIU20060272U0 (fi) Kotelo
TWM300109U (en) Ointment plaster adhesive structure
ATE517618T1 (de) Bisoprolol enthaltende klebende zubereitung
DK2074606T3 (da) Sammensat stempel
ITFI20060271A1 (it) Case per pc

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B25A Requested transfer of rights approved

Owner name: NITTO DENKO CORPORATION (JP)

B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO ELETRONICA WBRJ NO 860140192511 DE 18/11/2014.